United States · FDA National Drug Code directory
BUPRENORPHINE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72162-1345_510785c6-1456-4a79-a4a2-7e8eec746bbd
- Product NDC
- 72162-1345
- Form
- TABLET
- Composition / generic term
- BUPRENORPHINE
- Labeler
- Bryant Ranch Prepack
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20171025
- Source listing expiry
- 20271231
Source-listed ingredients
- BUPRENORPHINE HYDROCHLORIDE — 8 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 120 TABLET in 1 BOTTLE (72162-1345-0) · 72162-1345-0
- 60 TABLET in 1 BOTTLE (72162-1345-2) · 72162-1345-2
- 30 TABLET in 1 BOTTLE (72162-1345-3) · 72162-1345-3
- 20 TABLET in 1 BOTTLE (72162-1345-4) · 72162-1345-4
- 7 TABLET in 1 BOTTLE (72162-1345-5) · 72162-1345-5
- 28 TABLET in 1 BOTTLE (72162-1345-6) · 72162-1345-6
- 1 TABLET in 1 BOTTLE (72162-1345-7) · 72162-1345-7
- 12 TABLET in 1 BOTTLE (72162-1345-8) · 72162-1345-8
- 14 TABLET in 1 BOTTLE (72162-1345-9) · 72162-1345-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →